Condensed Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Total	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]
Beginning Balance at Dec. 31, 2023	$ (2,579,537)	$ 28	$ 120,859,873	$ (123,439,438)
Beginning Balance, Shares at Dec. 31, 2023		278,558
Stock-based compensation expense	254,029		254,029
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants, net of issuance costs	6,172,623	$ 43	6,172,580
Issuance of common stock, Pre-Funded Warrants, Series A Warrants, Series B Warrants, and Series C Warrants, net of issuance costs, shares		427,886
Amendment and issuance of common stock and Pre-Funded Warrants from the March 2024 Amendment of Series B Warrants and Series C Warrants, net of issuance costs	1,229,874	$ 1	1,229,873
Amendment and issuance of common stock and Pre-Funded Warrants from the March 2024 Amendment of Series B Warrants and Series C Warrants, net of issuance costs, shares		9,967
Net loss	(1,579,820)			(1,579,820)
Ending Balance at Mar. 31, 2024	3,497,169	$ 72	128,516,355	(125,019,258)
Ending Balance, Shares at Mar. 31, 2024		716,411
Beginning Balance at Dec. 31, 2024	$ 7,038,010	$ 149	135,829,493	(128,791,632)
Beginning Balance, Shares at Dec. 31, 2024	1,486,009	1,486,009
Stock-based compensation expense	$ 84,384		84,384
Issuance of common stock pursuant to the ESPP	24,999		24,999
Issuance of common stock pursuant to the ESPP, Shares		6,849
Net loss	(1,306,178)			(1,306,178)
Ending Balance at Mar. 31, 2025	$ 5,841,215	$ 149	$ 135,938,876	$ (130,097,810)
Ending Balance, Shares at Mar. 31, 2025	1,492,858	1,492,858